The table below shows WEST PHARMACEUTICAL SERVICES INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$89.90M
$129.40M
$118.20M
$138.10M
$151.20M
$88.70M
Capital expenditure
$42.70M
$71.30M
$90.60M
$82.10M
$65.80M
$54.70M
Investing cash flow
-$42.70M
-$71.30M
-$90.60M
-$82.10M
-$68.30M
-$54.50M
Dividends paid
$15.80M
$15.20M
$14.70M
$14.10M
WST operating cash flow (10-K history)
WEST PHARMACEUTICAL SERVICES INC reported operating cash flow of $754.80M for fiscal year 2025. That is up 15.5% from $653.40M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $219.40M (FY 2016) to $754.80M. Figures come from the company's audited annual reports as filed with the SEC.
